Correlation Between Valneva SE and Veracyte
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Veracyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Veracyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Veracyte, you can compare the effects of market volatilities on Valneva SE and Veracyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Veracyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Veracyte.
Diversification Opportunities for Valneva SE and Veracyte
-0.89 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Valneva and Veracyte is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Veracyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veracyte and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Veracyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veracyte has no effect on the direction of Valneva SE i.e., Valneva SE and Veracyte go up and down completely randomly.
Pair Corralation between Valneva SE and Veracyte
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Veracyte. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.07 times less risky than Veracyte. The stock trades about -0.58 of its potential returns per unit of risk. The Veracyte is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 3,500 in Veracyte on August 31, 2024 and sell it today you would earn a total of 789.00 from holding Veracyte or generate 22.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Valneva SE ADR vs. Veracyte
Performance |
Timeline |
Valneva SE ADR |
Veracyte |
Valneva SE and Veracyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Valneva SE and Veracyte
The main advantage of trading using opposite Valneva SE and Veracyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Veracyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veracyte will offset losses from the drop in Veracyte's long position.Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |